Literature DB >> 16465514

Hypoxia-induced increase of endostatin in murine aorta and lung.

Renate Paddenberg1, Petra Faulhammer, Anna Goldenberg, Wolfgang Kummer.   

Abstract

In the lung, hypoxia induces pulmonary hypertension caused by vasoconstriction and vascular remodeling. Additionally, hypoxia is an inducer of angiogenesis, which is assumed to counteract pulmonary hypertension. We asked whether the anti-angiogenic factor endostatin--a cleavage product of collagen XVIII--participates in the vascular alterations induced by hypoxia. By employing Western blotting of tissue extracts of murine brain, liver and heart an endostatin fragment of 22 kDa was detectable, whereas in lung and aorta additional bands of 24 and 26 kDa were found. The amount of these larger fragments was increased in tissues obtained from mice housed for 4 days or 3 weeks at hypobaric hypoxia. By immunohistochemistry endostatin was detected in association with elastic fibers and in close neighborhood to smooth muscle cells of intrapulmonary vessels and the aorta. In the lung, the activity of matrix metalloproteinases (MMP) known to generate endostatin by cleavage of collagen XVIII was increased (MMP-2) and decreased (proMMP-9), respectively, by hypoxia. Elevated amounts of endostatin within the aortic wall of mice exposed to hypobaric hypoxia may stabilize the vascular wall by inhibition of microvascular sprouting. The surprising finding of increased endostatin in the lung presumably contributes to the development of pulmonary hypertension by reduction of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465514     DOI: 10.1007/s00418-006-0158-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  37 in total

1.  Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension.

Authors:  E Frisdal; V Gest; A Vieillard-Baron; M Levame; H Lepetit; S Eddahibi; C Lafuma; A Harf; S Adnot; M P Dortho
Journal:  Eur Respir J       Date:  2001-11       Impact factor: 16.671

2.  Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding.

Authors:  N Yamaguchi; B Anand-Apte; M Lee; T Sasaki; N Fukai; R Shapiro; I Que; C Lowik; R Timpl; B R Olsen
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

3.  Novel glycosylated forms of human plasma endostatin and circulating endostatin-related fragments of collagen XV.

Authors:  H John; K T Preissner; W G Forssmann; L Ständker
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

4.  Localization of endostatin in rat and human gliomas.

Authors:  H M Strik; H J Schluesener; K Seid; R Meyermann; M H Deininger
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

5.  Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

Authors:  Syed H E Zaidi; Xiao-Mang You; Sorana Ciura; Mansoor Husain; Marlene Rabinovitch
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

6.  Characterization of matrix metalloproteinases produced by rat alveolar macrophages.

Authors:  D F Gibbs; R L Warner; S J Weiss; K J Johnson; J Varani
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

7.  Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria.

Authors:  Martin H Deininger; Birte Fimmen; Peter G Kremsner; Richard Meyermann; Hermann J Schluesener
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

8.  Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.

Authors:  Marie-Aude Pascaud; Frank Griscelli; William Raoul; Elisabeth Marcos; Paule Opolon; Bernadette Raffestin; Michael Perricaudet; Serge Adnot; Saadia Eddahibi
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-24       Impact factor: 6.914

9.  N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.

Authors:  Heeyeong Cho; Woo Jean Kim; You Mie Lee; Young-Mi Kim; Young-Guen Kwon; Yong Suk Park; Eu-Yul Choi; Kyu-Won Kim
Journal:  Oncol Rep       Date:  2004-01       Impact factor: 3.906

10.  Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.

Authors:  Pia Nyberg; Pia Heikkilä; Timo Sorsa; Jani Luostarinen; Ritva Heljasvaara; Ulf-Håkan Stenman; Taina Pihlajaniemi; Tuula Salo
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

View more
  9 in total

Review 1.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 2.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 3.  Hypoxia-regulated angiogenic inhibitors.

Authors:  Angela Messmer-Blust; Xiaojin An; Jian Li
Journal:  Trends Cardiovasc Med       Date:  2009-11       Impact factor: 6.677

Review 4.  Endothelium under stress: local and systemic messages.

Authors:  Sergey V Brodsky; Michael S Goligorsky
Journal:  Semin Nephrol       Date:  2012-03       Impact factor: 5.299

5.  Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells.

Authors:  Clément Faye; Antonio Inforzato; Marine Bignon; Daniel J Hartmann; Laurent Muller; Lionel Ballut; Bjorn R Olsen; Anthony J Day; Sylvie Ricard-Blum
Journal:  Biochem J       Date:  2010-04-14       Impact factor: 3.857

6.  Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?

Authors:  Chi Hua Sarah Lin; Jun Chen; Bruce Ziman; Shannon Marshall; Julien Maizel; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-11       Impact factor: 4.733

7.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

8.  Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.

Authors:  Ping Zhang; Ying-Xin Qi; Qing-Ping Yao; Xiao-Hu Chen; Guo-Liang Wang; Bao-Rong Shen; Yue Han; Li-Zhi Gao; Zong-Lai Jiang
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

9.  Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonary anastamosis.

Authors:  Aida Field-Ridley; Ritva Heljasvaara; Taina Pihlajaniemi; Ian Adatia; Christine Sun; Roberta L Keller; Wen Hui Gong; Sanjeev Datar; Peter Oishi; Jeffrey R Fineman
Journal:  Pediatr Cardiol       Date:  2012-09-08       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.